Alterity Therapeutics Limited (ASX:ATH)
Australia · Delayed Price · Currency is AUD 0.6000
+0.0150 (2.56%)
Jun 19, 2026, 4:10 PM AEST
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of 130.5 million as of June 18, 2026. Its market cap has increased by 29.98% in one year.
Market Cap
130.50M
Enterprise Value
81.40M
Revenue
6.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.60
Market Cap Chart
Since March 28, 2000, Alterity Therapeutics's market cap has increased from 51.51M to 130.50M, an increase of 153.36%. That is a compound annual growth rate of 3.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 130.50M | 50.00% |
| Dec 31, 2025 | 87.00M | 104.41% |
| Dec 31, 2024 | 42.56M | 116.97% |
| Dec 29, 2023 | 19.62M | -18.82% |
| Dec 30, 2022 | 24.16M | -52.19% |
| Dec 31, 2021 | 50.54M | -19.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 209.64M |
| Recce Pharmaceuticals | 147.48M |
| Actinogen Medical | 117.05M |
| Dimerix | 114.08M |
| Nyrada | 112.68M |
| Island Pharmaceuticals | 109.49M |
| Paradigm Biopharmaceuticals | 94.58M |
| LTR Pharma | 92.71M |